All

What are you looking for?

All
Projects
Results
Organizations

Quick search

  • Projects supported by TA ČR
  • Excellent projects
  • Projects with the highest public support
  • Current projects

Smart search

  • That is how I find a specific +word
  • That is how I leave the -word out of the results
  • “That is how I can find the whole phrase”

MicroRNA Profiling of Bone Marrow Plasma Extracellular Vesicles in Multiple Myeloma, Extramedullary Disease, and Plasma Cell Leukemia

The result's identifiers

  • Result code in IS VaVaI

    <a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00027162%3A_____%2F25%3AN0000008" target="_blank" >RIV/00027162:_____/25:N0000008 - isvavai.cz</a>

  • Alternative codes found

    RIV/00216224:14110/25:00140487 RIV/65269705:_____/25:00081135

  • Result on the web

    <a href="https://onlinelibrary.wiley.com/doi/10.1002/hon.70036" target="_blank" >https://onlinelibrary.wiley.com/doi/10.1002/hon.70036</a>

  • DOI - Digital Object Identifier

    <a href="http://dx.doi.org/10.1002/hon.70036" target="_blank" >10.1002/hon.70036</a>

Alternative languages

  • Result language

    angličtina

  • Original language name

    MicroRNA Profiling of Bone Marrow Plasma Extracellular Vesicles in Multiple Myeloma, Extramedullary Disease, and Plasma Cell Leukemia

  • Original language description

    Multiple myeloma is a plasma cell malignancy characterized by an abnormal increase in monoclonal immunoglobulins. Despitesignificant advances in treatment, some patients progress to more aggressive forms of multiple myeloma, including extra-medullary disease or plasma cell leukemia. Although the exact molecular mechanisms are not known, several studies haveconfirmed the involvement of small extracellular vesicle‐enriched microRNAs in multiple myeloma progression. Therefore, weperformed expression profiling of these molecules in bone marrow plasma of multiple myeloma, extramedullary disease, andplasma cell leukemia patients using small RNA sequencing to identify novel molecules involved in disease pathogenesis. Intotal, 42 microRNAs were significantly dysregulated among analyzed subgroups. Independent validation by RT‐qPCRconfirmed elevated levels of miR‐140‐3p, miR‐584‐5p, miR‐191‐5p, and miR‐143‐3p in multiple myeloma patients comparedto extramedullary disease and plasma cell leukemia patients. Subsequent statistical analysis revealed significant correlationsbetween patient clinical characteristics or flow cytometry parameters and microRNA expression. These results indicate thatdysregulation of microRNAs could contribute to multiple myeloma progression.

  • Czech name

  • Czech description

Classification

  • Type

    J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database

  • CEP classification

  • OECD FORD branch

    30204 - Oncology

Result continuities

  • Project

    Result was created during the realization of more than one project. More information in the Projects tab.

  • Continuities

    I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Others

  • Publication year

    2025

  • Confidentiality

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Data specific for result type

  • Name of the periodical

    Hematological Oncology

  • ISSN

    0278-0232

  • e-ISSN

    1099-1069

  • Volume of the periodical

    43

  • Issue of the periodical within the volume

    1

  • Country of publishing house

    US - UNITED STATES

  • Number of pages

    47

  • Pages from-to

  • UT code for WoS article

    001397146000001

  • EID of the result in the Scopus database

    2-s2.0-85214787722